fluorouracil has been researched along with Gastric Fistula in 1 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Gastric Fistula: Abnormal passage communicating with the STOMACH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasuya, G | 1 |
| Ogawa, K | 1 |
| Shimoji, H | 1 |
| Tamaki, W | 1 |
| Karimata, H | 1 |
| Toita, T | 1 |
| Kakinohana, Y | 1 |
| Ariga, T | 1 |
| Nishimaki, T | 1 |
| Murayama, S | 1 |
1 other study available for fluorouracil and Gastric Fistula
| Article | Year |
|---|---|
Development of gastro-lymphatic fistula during chemoradiotherapy for advanced esophageal cancer: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; G | 2009 |